Thus, our current study involves generation and characterization of early stage buccal mucosa oral cancer cell line, inflammasome activation model, and NLRP3 knockdown model of this cell line which can have immense applications for screening and developing therapeutic drugs for improved oral cancer management. This evidence concerns the gene NLRP3 and lip and oral cavity carcinoma.